Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today provides an update on its commercial and operational performance for the quarter ended 31 December 2024 (Q4 2024).

Patients who rely on Medicare have fewer options as more clinics stop taking new bulk-billed patients, according to a study ...

The ARMswap team is thrilled to announce the launch of its 1st version of its DeFi protocol. The web3 world is booming with numerous layer-1 and layer-2 blockchains, each having their unique ...